The estimated Net Worth of Christine A Pellizzari is at least $14.1 Million dollars as of 8 February 2021. Ms. Pellizzari owns over 21,550 units of Insmed Inc stock worth over $11,341,174 and over the last 11 years she sold INSM stock worth over $0. In addition, she makes $2,709,560 as Chief Legal Officer at Insmed Inc.
Christine has made over 6 trades of the Insmed Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently she exercised 21,550 units of INSM stock worth $233,818 on 8 February 2021.
The largest trade she's ever made was exercising 183,450 units of Insmed Inc stock on 15 May 2020 worth over $2,122,517. On average, Christine trades about 10,689 units every 56 days since 2013. As of 8 February 2021 she still owns at least 155,871 units of Insmed Inc stock.
You can see the complete history of Ms. Pellizzari stock trades at the bottom of the page.
Christine A. Pellizzari J.D. serves as Chief Legal Officer of the Company., is Chief Legal Officer of the Insmed Inc. Ms. Pellizzari joined Insmed as General Counsel and Corporate Secretary in July 2013 and was promoted to Chief Legal Officer in January 2018. Ms. Pellizzari has over 20 years of experience in the global biotechnology and pharmaceutical industry, including senior-level leadership roles. From August 2007 to December 2011, Ms. Pellizzari served as Executive Vice President, General Counsel and Secretary for Aegerion and served as a legal consultant for Aegerion from January 2012 to June 2012. From 1998 to 2007, Ms. Pellizzari served as Senior Vice President, General Counsel and Secretary of Dendrite International, Inc., a publicly traded company that provided the global pharmaceutical industry with sales effectiveness, promotional and compliance solutions until it was acquired by Cegedim S.A. in 2007. Prior to her tenure at Dendrite, Ms. Pellizzari practiced law at the firm of Wilentz, Goldman & Spitzer where she specialized in health care transactions and related regulatory matters. Before joining Wilentz, Ms. Pellizzari served as a law clerk to the Honorable Reginald Stanton, Assignment Judge for the Superior Court of New Jersey. Ms. Pellizzari received her Bachelor of Arts degree, cum laude, from the University of Massachusetts, Amherst and her Juris Doctor degree from the University of Colorado, Boulder.
As the Chief Legal Officer of Insmed Inc, the total compensation of Christine Pellizzari at Insmed Inc is $2,709,560. There are 2 executives at Insmed Inc getting paid more, with William Lewis having the highest compensation of $7,175,090.
Christine Pellizzari is 52, she's been the Chief Legal Officer of Insmed Inc since 2018. There are 14 older and 7 younger executives at Insmed Inc. The oldest executive at Insmed Inc is Steinar Engelsen, 70, who is the Independent Director.
Christine's mailing address filed with the SEC is C/O CELSION CORPORATION, 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ, 08648.
Over the last 21 years, insiders at Insmed Inc have traded over $46,121,705 worth of Insmed Inc stock and bought 1,080,212 units worth $8,226,993 . The most active insiders traders include Llc Fmr, William Lewis, and Dennis M Lanfear. On average, Insmed Inc executives and independent directors trade stock every 38 days with the average trade being worth of $2,452,158. The most recent stock trade was executed by Orlov S Nicole Schaeffer on 10 September 2024, trading 37,575 units of INSM stock currently worth $407,689.
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
Insmed Inc executives and other stock owners filed with the SEC include: